Avascular necrosis of the femoral heads after single corticosteroid injection

Gunal, Izge; Karatosun, Vasfi
July 2006
CMAJ: Canadian Medical Association Journal;7/4/2006, Vol. 175 Issue 1, p32
Academic Journal
Discusses a case of avascular necrosis of the femoral heads in a patient with minimal tenderness over his hips and mild limitation of his range of motion. Role of corticosteroid injection in the development of avascular necrosis; Other causes of avascular necrosis; Incidence rate of the medical condition.


Related Articles

  • Using Restronate to Prevent Steroid-Induced Bone Loss. Miller, Karl E. // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1167 

    Discusses the study `Risedronate Therapy Prevents Corticosteroid-Induced Bone Loss: A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study,' by S. Cohen and colleagues published in the November 1999 issue of the `Arthritis Rheumatism' journal.

  • Bone Loss Accompanying Medical Therapies. Dawson-Hughes, Bess // New England Journal of Medicine;9/27/2001, Vol. 345 Issue 13, p989 

    Editorial. Discusses two studies which report that the treatment of a primary medical condition can result in accelerated bone loss. Description of the two studies, which focused on bone loss during prostate cancer treatment with leuprolide and the effect of glucocorticoids on the bone mass of...

  • Does Adjunctive Chemotherapy Reduce Remission Rates Compared to Cortisone Alone in Unifocal or Multifocal Histiocytosis of Bone? Baptista, AndrĂ©; Camargo, AndrĂ©; Camargo, Olavo; Odone Filho, Vicente; Cassone, Alejandro // Clinical Orthopaedics & Related Research;Mar2012, Vol. 470 Issue 3, p663 

    Background: Langerhans cell histiocytosis (LCH) is a rare disorder that can affect almost any organ, including bone. Treatment options include local corticosteroid infiltration in isolated bone lesions and oral corticosteroids and chemotherapy in multifocal bone lesions. Several studies show...

  • Glaucoma risk increased with long-term, high-dose inhaled corticosteroids.  // Geriatrics;June97, Vol. 52 Issue 6, p20 

    Focuses on the long-term use of very high doses of inhaled corticosteroids may increase the risk of glaucoma, according to study by Canadian researchers. Patients who are only treated with high doses of corticosteroids; Advices for doctors treating patients with corticosteroids.

  • Inhaled corticosteroids and adrenal suppression.  // WHO Drug Information;2002, Vol. 16 Issue 3, p231 

    Reports on the British Committee of Safety of Medicines' reminder to prescribers that adrenal suppression is a well-established adverse reaction to all inhaled corticosteroids. Cases of adrenal suppression leading to adrenal crisis; Possible unrecognition of signs and symptoms.

  • Fluticasone propionate.  // Reactions Weekly;2/4/2012, Issue 1387, p19 

    The article describes the case of a 56-year-old woman with a history of bronchiectasis and chronic obstructive pulmonary disease (COPD) who developed allergic bronchopulmonary aspergillosis during treatment with corticosteroids that included fluticasone propionate.

  • Clobetasol.  // Reactions Weekly;12/8/2012, Issue 1431, p15 

    The article describes the case of a 56-year-old man who developed femoral head osteonecrosis while receiving clobetasol for psoriasis.

  • Mometasone.  // Reactions Weekly;10/6/2012, Issue 1422, p35 

    The article describes the case of a 68-year-old man who developed an acquired loss of fingerprints while receiving mometasone for the treatment of pompholyx hand eczema.

  • Fluocinolone acetonide.  // Reactions Weekly;11/17/2012, Issue 1428, p18 

    The article describes the case of a 26-year-old woman who developed clinical signs of Cushing's syndrome such as buffalo hump, abdominal obesity, acneiform rash on her face and moon face, during fluocinolone acetonide therapy for oral lichen planus.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics